All Circulars (27354)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises price bands for 12 listed scrips effective March 11, 2026, with bands ranging from 2% to 20% across various equity securities. | |||||||||||||||
BSE revises price bands for 12 listed scrips effective March 11, 2026, with bands ranging from 2% to 20% across various equity securities.
| |||||||||||||||
BSE publishes clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news items appearing in financial media, … | |||||||||||||||
BSE publishes clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news items appearing in financial media, including RailTel's MoU with GAIL for digital infrastructure and Uno Minda's new trumpet horn product launch.
| |||||||||||||||
BSE sought clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news articles and share price movements. … | |||||||||||||||
BSE sought clarifications from RailTel Corporation of India Ltd. and Uno Minda Limited regarding news articles and share price movements. RailTel confirmed a non-binding MoU with GAIL for digital infrastructure, while Uno Minda clarified a product launch news item.
| |||||||||||||||
BSE received clarifications from Emcure Pharmaceuticals Ltd and Landmark Global Learning Ltd regarding significant increase in volume/price … | |||||||||||||||
BSE received clarifications from Emcure Pharmaceuticals Ltd and Landmark Global Learning Ltd regarding significant increase in volume/price movement of their securities, both companies stating the movement is market-driven with no undisclosed material information.
| |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed … | |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed price-sensitive information exists behind recent significant volume/price movements in their scrips.
| |||||||||||||||
SEBI notifies completion of Recovery Certificate No. 8587 of 2025 dated January 24, 2025, issued to defaulter SAROJ BAID (PAN: AHTPB7233L) … | |||||||||||||||
SEBI notifies completion of Recovery Certificate No. 8587 of 2025 dated January 24, 2025, issued to defaulter SAROJ BAID (PAN: AHTPB7233L) in the matter of trading in illiquid stock options on BSE.
| |||||||||||||||
BSE has made available the penalty report for modification of client codes of non-institutional trades across all segments for February … | |||||||||||||||
BSE has made available the penalty report for modification of client codes of non-institutional trades across all segments for February 2026. Members can download the file PM0226.Clg from the EQUITY TRANSACTION FOLDER in Extranet.
| |||||||||||||||
BSE circular announcing 3 securities newly shortlisted under the Enhanced Surveillance Measure (ESM) framework effective March 11, 2026, … | |||||||||||||||
BSE circular announcing 3 securities newly shortlisted under the Enhanced Surveillance Measure (ESM) framework effective March 11, 2026, with no securities moving out and a consolidated list of all ESM securities.
| |||||||||||||||
BSE announces addition of 3 securities to the Enhanced Surveillance Measure (ESM) framework effective March 11, 2026, along with the … | |||||||||||||||
BSE announces addition of 3 securities to the Enhanced Surveillance Measure (ESM) framework effective March 11, 2026, along with the consolidated list of all securities under ESM.
| |||||||||||||||
NSE directs all members to furnish details of excess STT collected and retained for FY 2023-24 and prior years, and remit the amount with 1% … | |||||||||||||||
NSE directs all members to furnish details of excess STT collected and retained for FY 2023-24 and prior years, and remit the amount with 1% monthly interest within 7 days, as per Income Tax department instructions.
| |||||||||||||||